Zhejiang Orient Gene Biotech Co., Ltd
688298.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.93B
Close$
$-7.74
141.1% downside
Current Fair Value
141.1% downsideOvervalued by 141.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.93 Billion |
|---|---|
| Enterprise Value | $1.96 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.93 |
| Beta | 0.83 |
| Outstanding Shares | 191,516,590 |
Return
| Return on Equity | -10.82% |
|---|---|
| Return on Assets | -9.03% |
| Return on Invested Capital | -10.13% |
Valuation & Multiples
| P/E Ratio | -5.96 |
|---|---|
| PEG | -3.52 |
| Price to Sales | 3.77 |
| Price to Book Ratio | 0.63 |
| Enterprise Value to Revenue | 1.93 |
| Enterprise Value to EBIT | -3.23 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Orient Gene Biotech Co., Ltd
2,068 employees
CEO: Xiao Liang Fang Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, ...